Wilfried Wormsbächer

Title: Wilfried Wormsbächer: Innovator in Biopharmaceuticals

Introduction

Wilfried Wormsbächer is a notable inventor based in Kirchhain, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of modified coagulation factors. His work has led to advancements that enhance the stability and efficacy of therapeutic proteins.

Latest Patents

Wormsbächer holds 2 patents that focus on innovative solutions in the realm of coagulation factors. His first patent, titled "Modified coagulation factor VIIa with extended half-life," pertains to cDNA sequences coding for human Factor VII and Factor VIIa. This invention aims to improve the stability and functional plasma half-life of these proteins through genetic modifications. The second patent, "Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto," describes a process for producing a concentrated form of von Willebrand factor that enhances the content of high molecular weight multimers, thereby improving therapeutic outcomes.

Career Highlights

Wormsbächer is currently associated with CSL Behring GmbH, a leading company in the biopharmaceutical industry. His work at CSL Behring has been instrumental in advancing treatments for bleeding disorders. His innovative approaches have positioned him as a key figure in the development of life-saving therapies.

Collaborations

Throughout his career, Wormsbächer has collaborated with esteemed colleagues, including Stefan Schulte and Thomas Weimer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.

Conclusion

Wilfried Wormsbächer's contributions to biopharmaceuticals through his patents and work at CSL Behring highlight his role as a significant innovator in the industry. His advancements in coagulation factors continue to impact the treatment of patients with bleeding disorders.